News
The cardiology team at the MemorialCare Heart & Vascular Institute at Long Beach Medical Center, led by Chief of Cardiology ...
8d
Medical Device Network on MSNFDA approves Abbott’s TMVR system to treat mitral valve diseaseThe system is available for patients whose mitral valves are not working properly due to severe mitral annular calcification.
The transcatheter mitral valve replacement (TMVR) market is projected to grow at a CAGR of 20% over the forecast ...
The research showed that after a diagnosis of aortic stenosis, women are 11% less likely to be referred on to secondary care ...
3d
News-Medical.Net on MSNDual treatment strategy offers survival advantage for patients with severe heart diseaseAortic valve narrowing (aortic stenosis) with concomitant cardiac amyloidosis is a severe heart disease of old age that is ...
Aortic valve narrowing (aortic stenosis) with concomitant cardiac amyloidosis is a severe heart disease of old age that is ...
First-Ever Non-Surgical Transcatheter tricuspid Valve Replacement (TTVR-ViV ) Performed in Rajasthan
In a major medical breakthrough for Rajasthan, doctors at Eternal Hospital, Jaipur, have successfully replaced the tricuspid ...
The FDA gave the OK for the North Chicago-based medical device maker's Tendyne transcatheter mitral valve replacement.
The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify ...
Edwards Lifesciences, a leader in heart medical devices, has shown strong growth, innovation, and attractive valuation. Read ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results